Endometrium Archives - Page 2 of 4 - Revista Brasileira de Ginecologia e Obstetrícia
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(6):325-331
DOI 10.1590/S0100-72032000000600002
Purpose: to evaluate the efficacy of medroxyprogesterone acetate and megestrol acetate in endometrial hyperplasia. Patients and Methods: forty-seven patients with abnormal uterine bleeding were retrospectively evaluated. These patients were submitted to diagnostic uterine curettage and/or endometrial biopsy, with histopathological finding of endometrial hyperplasia. Patients with hyperplasia without atypia received 10 mg/day oral medroxyprogesterone acetate during 10 to 12 days a month. Those with hyperplasia with atypia received 160 mg/day oral megestrol acetate continuously. The length of treatment ranged from 3 to 18 months. Control endometrial biopsy and/or uterine curettage were performed 3 and 6 months from the beginning of treatment, and then periodically to evaluate whether or not regression of hyperplasia occurred. Results: forty-two patients with endometrial hyperplasia without atypia and 5 with hyperplasia with atypia were included. The mean age of the patients was 49.5 ± 10.6 years (22 to 72 years), 70.2% aged over 45 years. Medroxy-progesterone acetate was effective in promoting regression of 83.2% (35/42) of hyperplasia without atypia, and megestrol acetate in 80% (4/5) of hyperplasia with atypia. Despite treatment, lesions persisted in 16.8% (7 cases) of hyperplasia with atypia and in 20% (1 case) of hyperplasia without atypia. No progression to endometrial cancer was seen during the follow-up period of 3 months to 9 years. During follow-up, we found that 18 patients (38.3%) showed amenorrhea, 12 (25.5%) menstrual cycle regulation, and 17 (36.2%) persistent abnormal uterine bleeding and underwent total abdominal hysterectomy. Histological examination of the uterus showed 8 patients with persistence of hyperplastic lesion, 4 with leiomyoma, 3 with adenomyosis, 1 with diffuse uterine myohypertrophy, and 1 with normal uterus, despite regression of the hyperplastic lesions in 9 of the 17 patients. Conclusions: the treatment of endometrial hyperplasia with medroxyprogesterone acetate and megestrol acetate can be a safe alternative for women who refuse to have their uterus removed or those at high risk for surgery. However, a careful monitoring of the endometrium is needed. This can be achieved with periodical endometrial biopsy, transvaginal ultrasonography, and evaluation of the symptoms.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(6):325-331
DOI 10.1590/S0100-72032000000600002
Purpose: to evaluate the efficacy of medroxyprogesterone acetate and megestrol acetate in endometrial hyperplasia. Patients and Methods: forty-seven patients with abnormal uterine bleeding were retrospectively evaluated. These patients were submitted to diagnostic uterine curettage and/or endometrial biopsy, with histopathological finding of endometrial hyperplasia. Patients with hyperplasia without atypia received 10 mg/day oral medroxyprogesterone acetate during 10 to 12 days a month. Those with hyperplasia with atypia received 160 mg/day oral megestrol acetate continuously. The length of treatment ranged from 3 to 18 months. Control endometrial biopsy and/or uterine curettage were performed 3 and 6 months from the beginning of treatment, and then periodically to evaluate whether or not regression of hyperplasia occurred. Results: forty-two patients with endometrial hyperplasia without atypia and 5 with hyperplasia with atypia were included. The mean age of the patients was 49.5 ± 10.6 years (22 to 72 years), 70.2% aged over 45 years. Medroxy-progesterone acetate was effective in promoting regression of 83.2% (35/42) of hyperplasia without atypia, and megestrol acetate in 80% (4/5) of hyperplasia with atypia. Despite treatment, lesions persisted in 16.8% (7 cases) of hyperplasia with atypia and in 20% (1 case) of hyperplasia without atypia. No progression to endometrial cancer was seen during the follow-up period of 3 months to 9 years. During follow-up, we found that 18 patients (38.3%) showed amenorrhea, 12 (25.5%) menstrual cycle regulation, and 17 (36.2%) persistent abnormal uterine bleeding and underwent total abdominal hysterectomy. Histological examination of the uterus showed 8 patients with persistence of hyperplastic lesion, 4 with leiomyoma, 3 with adenomyosis, 1 with diffuse uterine myohypertrophy, and 1 with normal uterus, despite regression of the hyperplastic lesions in 9 of the 17 patients. Conclusions: the treatment of endometrial hyperplasia with medroxyprogesterone acetate and megestrol acetate can be a safe alternative for women who refuse to have their uterus removed or those at high risk for surgery. However, a careful monitoring of the endometrium is needed. This can be achieved with periodical endometrial biopsy, transvaginal ultrasonography, and evaluation of the symptoms.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2003;25(6):396-401
DOI 10.1590/S0100-72032003000600003
PURPOSE: to evaluate the significance of neoangiogenesis for the prognosis of endometrial carcinoma, by quantifying and comparing the vessels with the grade of histologic differentiation and tumor staging. METHODS: the 56 studied cases consisted of 11 atrophic endometria, 10 proliferative endometria, 10 GI, 13 GII and 12 GIII adenocarcinomas. Two histologic sections were obtained for each case: one was stained with hematoxylin-eosin and the other was sent for a immunohistochemical study with anti-CD34. The utilized histometric method was vessel counting at the tumoral growth interface with the adjacent stroma, and in the control group, at the endometrial gland interface with the stroma. Couting was done by a KS300, evaluating 10 fields at 100X magnification. RESULTS: the counted vessel means were 11.6 for atrophic endometria, 13.2 for proliferative endometria, 15.3 for GI adenocarcinoma, 19 for GII adenocarcinoma, and 22.7 for GIII adenocarcinoma. In the group of stage I patients, it was observed that the mean number of vessels (18.6) was similar to that observed in stages II, III and IV (20.9) computed together. CONCLUSION: less differentiated adenocarcinomas were more angiogenic than well-differentiated carcinomas and normal endometrium. Vessel counting was not influenced by the disease stage as an isolated factor.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2003;25(6):396-401
DOI 10.1590/S0100-72032003000600003
PURPOSE: to evaluate the significance of neoangiogenesis for the prognosis of endometrial carcinoma, by quantifying and comparing the vessels with the grade of histologic differentiation and tumor staging. METHODS: the 56 studied cases consisted of 11 atrophic endometria, 10 proliferative endometria, 10 GI, 13 GII and 12 GIII adenocarcinomas. Two histologic sections were obtained for each case: one was stained with hematoxylin-eosin and the other was sent for a immunohistochemical study with anti-CD34. The utilized histometric method was vessel counting at the tumoral growth interface with the adjacent stroma, and in the control group, at the endometrial gland interface with the stroma. Couting was done by a KS300, evaluating 10 fields at 100X magnification. RESULTS: the counted vessel means were 11.6 for atrophic endometria, 13.2 for proliferative endometria, 15.3 for GI adenocarcinoma, 19 for GII adenocarcinoma, and 22.7 for GIII adenocarcinoma. In the group of stage I patients, it was observed that the mean number of vessels (18.6) was similar to that observed in stages II, III and IV (20.9) computed together. CONCLUSION: less differentiated adenocarcinomas were more angiogenic than well-differentiated carcinomas and normal endometrium. Vessel counting was not influenced by the disease stage as an isolated factor.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2003;25(4):237-241
DOI 10.1590/S0100-72032003000400003
PURPOSE: to investigate the accuracy of hysteroscopy as a method for the evaluation of the uterine cavity in women with postmenopausal bleeding. METHODS: a cross-sectional study that consisted of the evaluation of 78 women with postmenopausal bleeding submitled to histeroscopy and directed biopsy in the period from January 2000 to June 2002 in the Bahia State Oncology Center. Hysteroscopy findings were classified as benign (leiomyoma, polyp, atrophy, normal) and suspect (hyperplasia, thickening, cancer) and the histopathologic findings as benign (leiomyoma, polyp, non-atypical hyperplasia, atrophy) and malignant (cancer and atypical hyperplasia). The results of hysteroscopy were compared with the pathologic findings. RESULTS: in relation to the suspect results (thickening, hyperplasia and cancer) hysteroscopy sensitivity and specificity were 85.7 and 88.7%, respectively. Positive and negative predictive values were 42.83 and 98.4%. Likelihood ratios of positive and negative tests were 7.6 and 0.16. Accuracy was 88.4% and kappa index, 0.5. CONCLUSION: hysteroscopy alone did not show an acceptable accuracy in the study, reinforcing the idea that its main advantage is to direct the biopsy, and it must always be associated with the histological diagnosis.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2003;25(4):237-241
DOI 10.1590/S0100-72032003000400003
PURPOSE: to investigate the accuracy of hysteroscopy as a method for the evaluation of the uterine cavity in women with postmenopausal bleeding. METHODS: a cross-sectional study that consisted of the evaluation of 78 women with postmenopausal bleeding submitled to histeroscopy and directed biopsy in the period from January 2000 to June 2002 in the Bahia State Oncology Center. Hysteroscopy findings were classified as benign (leiomyoma, polyp, atrophy, normal) and suspect (hyperplasia, thickening, cancer) and the histopathologic findings as benign (leiomyoma, polyp, non-atypical hyperplasia, atrophy) and malignant (cancer and atypical hyperplasia). The results of hysteroscopy were compared with the pathologic findings. RESULTS: in relation to the suspect results (thickening, hyperplasia and cancer) hysteroscopy sensitivity and specificity were 85.7 and 88.7%, respectively. Positive and negative predictive values were 42.83 and 98.4%. Likelihood ratios of positive and negative tests were 7.6 and 0.16. Accuracy was 88.4% and kappa index, 0.5. CONCLUSION: hysteroscopy alone did not show an acceptable accuracy in the study, reinforcing the idea that its main advantage is to direct the biopsy, and it must always be associated with the histological diagnosis.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2003;25(4):229-235
DOI 10.1590/S0100-72032003000400002
PURPOSE: to determine the association between ultrasonographic, hysteroscopic and histopathologic findings in women with postmenopausal uterine bleeding. METHODS: a retrospective, cross-sectional study was conducted enrolling 156 women with postmenopausal bleeding attended at the Diagnostic Center - IMIP during the period of January 1995 to December 2001. According to the results of the endometrial examination (ultrasound), the patients were classified as having an abnormal or normal finding depending on the cutoffs of 4 or 5 mm. The most common histologic and hysteroscopic findings were studied and classified as premalignant/malignant lesions (hyperplasia/endometrial cancer) or benign findings. These results were compared using the kappa index, to establish the agreement between these techniques. RESULTS: the frequency of endometrial thickening was 75.0 and 67.3% according to cutoffs of 4 mm and 5 mm, respectively. Hysteroscopic findings were atrophic endometrium in 59 (37.8%), endometrial polyp in 56 (35.9%), endometrial hyperplasia in 17 (10.9%), cancer in 16 (10.3%), still active endometrium in 1 (3,2), and other findings in 3 (1.9%). The two most frequent histopathologic findings were also atrophic endometrium (31.4%) and endometrial polyps (26,.3%), followed by scanty material (16.0%), endometrial cancer (10.9%), endometrial hyperplastic changes (9.0%), and others (6.4%). A good agreement between hysteroscopic and histopathologic findings was observed (kappa = 0.61). CONCLUSIONS: the frequency of endometrial thickening was 75.0 and 67.3% according to cutoffs of 4 mm and 5 mm, respectively. No premalignant or malignant lesions were missed when an endometrial cutoff of 4 mm was used. The most frequent hysteroscopic and histopathologic findings were atrophic endometrium and endometrial polyps and a good agreement between these findings was encountered.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2003;25(4):229-235
DOI 10.1590/S0100-72032003000400002
PURPOSE: to determine the association between ultrasonographic, hysteroscopic and histopathologic findings in women with postmenopausal uterine bleeding. METHODS: a retrospective, cross-sectional study was conducted enrolling 156 women with postmenopausal bleeding attended at the Diagnostic Center - IMIP during the period of January 1995 to December 2001. According to the results of the endometrial examination (ultrasound), the patients were classified as having an abnormal or normal finding depending on the cutoffs of 4 or 5 mm. The most common histologic and hysteroscopic findings were studied and classified as premalignant/malignant lesions (hyperplasia/endometrial cancer) or benign findings. These results were compared using the kappa index, to establish the agreement between these techniques. RESULTS: the frequency of endometrial thickening was 75.0 and 67.3% according to cutoffs of 4 mm and 5 mm, respectively. Hysteroscopic findings were atrophic endometrium in 59 (37.8%), endometrial polyp in 56 (35.9%), endometrial hyperplasia in 17 (10.9%), cancer in 16 (10.3%), still active endometrium in 1 (3,2), and other findings in 3 (1.9%). The two most frequent histopathologic findings were also atrophic endometrium (31.4%) and endometrial polyps (26,.3%), followed by scanty material (16.0%), endometrial cancer (10.9%), endometrial hyperplastic changes (9.0%), and others (6.4%). A good agreement between hysteroscopic and histopathologic findings was observed (kappa = 0.61). CONCLUSIONS: the frequency of endometrial thickening was 75.0 and 67.3% according to cutoffs of 4 mm and 5 mm, respectively. No premalignant or malignant lesions were missed when an endometrial cutoff of 4 mm was used. The most frequent hysteroscopic and histopathologic findings were atrophic endometrium and endometrial polyps and a good agreement between these findings was encountered.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(10):619-625
DOI 10.1590/S0100-72032000001000004
Purpose: to compare the methods used to investigate the endouterine cavity by testing the sensitivity and specificity of X-ray hysterography and sonohysterography compared with hysteroscopy (gold standard). Methods: we carried out a prospective study with 18 patients who, due to symptoms such as irregular menstrual cycles, unexplained postmenopausal uterine bleeding and ultrasound disturbance, were candidates for uterine cavity investigation by X-ray hysterography, sonohysterography and hysteroscopy. Results: sonohysterography sensitivity and specificity were 90 and 87.5%, respectively. Positive and negative predictive values were 90 and 87.5%. For X-ray hysterography, sensitivity, specificity, positive and negative predictive values were 70, 75, 77.7 and 75%, respectively. Conclusion: the use of saline instilation into the endometrial cavity in order to enhance the acuracy of the vaginal ultrasonography seems reliable as a mean to distinguish lesions in the uterine cavity, thereby facilitating the identification of candidates for diagnostic or operative hysteroscopy. X-ray hysterography produces results inferior to hysterosonography.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(10):619-625
DOI 10.1590/S0100-72032000001000004
Purpose: to compare the methods used to investigate the endouterine cavity by testing the sensitivity and specificity of X-ray hysterography and sonohysterography compared with hysteroscopy (gold standard). Methods: we carried out a prospective study with 18 patients who, due to symptoms such as irregular menstrual cycles, unexplained postmenopausal uterine bleeding and ultrasound disturbance, were candidates for uterine cavity investigation by X-ray hysterography, sonohysterography and hysteroscopy. Results: sonohysterography sensitivity and specificity were 90 and 87.5%, respectively. Positive and negative predictive values were 90 and 87.5%. For X-ray hysterography, sensitivity, specificity, positive and negative predictive values were 70, 75, 77.7 and 75%, respectively. Conclusion: the use of saline instilation into the endometrial cavity in order to enhance the acuracy of the vaginal ultrasonography seems reliable as a mean to distinguish lesions in the uterine cavity, thereby facilitating the identification of candidates for diagnostic or operative hysteroscopy. X-ray hysterography produces results inferior to hysterosonography.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(8):495-502
DOI 10.1590/S0100-72032000000800005
Purpose: to critically evaluate the histopathologic findings and the cost/benefit relation of dilatation and uterine curettage (D&C) in the evaluation of the abnormal uterine bleeding (AUB). Method: retrospective analysis of the histopathological findings in 542 D&C performed for AUB in the Department of Gynecology of the Faculdade de Ciências Médicas da Universidade do Estado do Rio de Janeiro (FCM-UERJ), between January 1984 and January 1994. The patients were divided into two groups: Group 1 - patients <=50 years (385 D&C) and Group 2 -- patients >50 years (157 D&C). Cases of urgency curettage were excluded from the study. All the curettages were accomplished under narcosis. The mean hospitalization lenght was three days. A histopa-thological finding of proliferative, secretory, atrophic or iatrogenic type endometrium was considered a negative pathological result. The term iatrogenic refers to the endometrium under possible influence of hormonal medication. When the histopathological finding evidenced some lesion, this was considered a positive pathological result. Results: in Group 1 there was a negative pathological result in 50.2% of the cases, positive pathological result in 39.7% of the cases, and insufficient material for diagnosis (IMD) in 10.1% of the cases. Endometrial polyp and submucosal leiomyoma were found in only 5.5% and 4.4%, respectively. Cancer was an uncommon observation in that group, endometrial adenocarcinoma (EAC) (five cases) being found in only 1.3% of the cases, in a relation of 77 D&C to one EAC. In Group 2, a negative pathological result was observed in 38.3% of the cases, positive pathological result in 38.1% of the cases and IMD in 23.6% of the cases. Endometrial polyp and submucosal leiomyoma were found only in 5.1% and 0.6%, respectively. Malignant lesions were found in 12% of the cases EAC being 9.5% (15 cases), showing a relation of one EAC to 10 D&C. Conclusions: according to the current knowledge on the etiology of AUB, this study showed that traditional diagnostic D&C has low accuracy in the evaluation of AUB and a cost/benefit relation incompatible with current medicine. Therefore, it should not be the examination of first choice. Considering, however, that EAC was found in one of each 10 D&C in women >50 years with a complaint of uterine bleeding, D&C can be indicated with more liberality in that group, if hysteroscopy with directed biopsy is not available. Nowadays, D&C does not play such a significant a role in the diagnosis of AUB as it did some years ago. However, the procedure is still indicated in some situations and it cannot be abandoned, and its indication should obey restricted criteria.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2000;22(8):495-502
DOI 10.1590/S0100-72032000000800005
Purpose: to critically evaluate the histopathologic findings and the cost/benefit relation of dilatation and uterine curettage (D&C) in the evaluation of the abnormal uterine bleeding (AUB). Method: retrospective analysis of the histopathological findings in 542 D&C performed for AUB in the Department of Gynecology of the Faculdade de Ciências Médicas da Universidade do Estado do Rio de Janeiro (FCM-UERJ), between January 1984 and January 1994. The patients were divided into two groups: Group 1 - patients <=50 years (385 D&C) and Group 2 -- patients >50 years (157 D&C). Cases of urgency curettage were excluded from the study. All the curettages were accomplished under narcosis. The mean hospitalization lenght was three days. A histopa-thological finding of proliferative, secretory, atrophic or iatrogenic type endometrium was considered a negative pathological result. The term iatrogenic refers to the endometrium under possible influence of hormonal medication. When the histopathological finding evidenced some lesion, this was considered a positive pathological result. Results: in Group 1 there was a negative pathological result in 50.2% of the cases, positive pathological result in 39.7% of the cases, and insufficient material for diagnosis (IMD) in 10.1% of the cases. Endometrial polyp and submucosal leiomyoma were found in only 5.5% and 4.4%, respectively. Cancer was an uncommon observation in that group, endometrial adenocarcinoma (EAC) (five cases) being found in only 1.3% of the cases, in a relation of 77 D&C to one EAC. In Group 2, a negative pathological result was observed in 38.3% of the cases, positive pathological result in 38.1% of the cases and IMD in 23.6% of the cases. Endometrial polyp and submucosal leiomyoma were found only in 5.1% and 0.6%, respectively. Malignant lesions were found in 12% of the cases EAC being 9.5% (15 cases), showing a relation of one EAC to 10 D&C. Conclusions: according to the current knowledge on the etiology of AUB, this study showed that traditional diagnostic D&C has low accuracy in the evaluation of AUB and a cost/benefit relation incompatible with current medicine. Therefore, it should not be the examination of first choice. Considering, however, that EAC was found in one of each 10 D&C in women >50 years with a complaint of uterine bleeding, D&C can be indicated with more liberality in that group, if hysteroscopy with directed biopsy is not available. Nowadays, D&C does not play such a significant a role in the diagnosis of AUB as it did some years ago. However, the procedure is still indicated in some situations and it cannot be abandoned, and its indication should obey restricted criteria.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2002;24(4):233-239
DOI 10.1590/S0100-72032002000400004
Purpose: to analyze sensitivity, specificity, positive and negative predictive values and the likelihood ratio of transvaginal ultrasound and hysteroscopy when compared with the histopathologic examination of the endometrium in women with breast cancer who have been treated with tamoxifen. Methods: transversal study with 30 women in whom transvaginal ultrasound evaluated the echogenic pattern of endometrial echo and its thickness. Hyteroscopy was performed and described as normal (normal or atrophic endometrium) or abnormal (thickening, polyps, leiomyoma, synechia). Material for histopathology was obtained from endometrial biopsy and the findings were considered normal (irregular endometrial maturation and/or atrophy) or abnormal (polyps, simple or complex hyperplasia, leiomyoma or endometrial carcinoma). Results: the general diagnosis of endometrial modifications was present in 36.6% of patients. The most frequent results were cystic atrophy (46.6%) and endometrial polyps (26.6%). Through the ROC curve the best cutoff of 8 mm of endometrial thickness measure was determined. This measure showed sensitivity of 72.7%, specificity of 72.9%, positive predictive value of 66.6%, negative predictive value of 83.3% and likelihood ratio of 3.4. Hysteroscopy showed sensitivity of 90.9%, specificity of 68.4%, positive predictive value of 62.5%, negative prediction value of 92.8% and likelihood ratio of 2.8. Conclusions: the most frequent endometrial modifications were cystic atrophy followed by polyps. Transvaginal ultrasound showed a higher rate of false-positive (42.1%), when the cutoff for the thickness of the endometrium was 5 mm; however acuracy improved when the measure of 8 mm was used. The cutoff of 8 mm was determined through the ROC curve.
Summary
Revista Brasileira de Ginecologia e Obstetrícia. 2002;24(4):233-239
DOI 10.1590/S0100-72032002000400004
Purpose: to analyze sensitivity, specificity, positive and negative predictive values and the likelihood ratio of transvaginal ultrasound and hysteroscopy when compared with the histopathologic examination of the endometrium in women with breast cancer who have been treated with tamoxifen. Methods: transversal study with 30 women in whom transvaginal ultrasound evaluated the echogenic pattern of endometrial echo and its thickness. Hyteroscopy was performed and described as normal (normal or atrophic endometrium) or abnormal (thickening, polyps, leiomyoma, synechia). Material for histopathology was obtained from endometrial biopsy and the findings were considered normal (irregular endometrial maturation and/or atrophy) or abnormal (polyps, simple or complex hyperplasia, leiomyoma or endometrial carcinoma). Results: the general diagnosis of endometrial modifications was present in 36.6% of patients. The most frequent results were cystic atrophy (46.6%) and endometrial polyps (26.6%). Through the ROC curve the best cutoff of 8 mm of endometrial thickness measure was determined. This measure showed sensitivity of 72.7%, specificity of 72.9%, positive predictive value of 66.6%, negative predictive value of 83.3% and likelihood ratio of 3.4. Hysteroscopy showed sensitivity of 90.9%, specificity of 68.4%, positive predictive value of 62.5%, negative prediction value of 92.8% and likelihood ratio of 2.8. Conclusions: the most frequent endometrial modifications were cystic atrophy followed by polyps. Transvaginal ultrasound showed a higher rate of false-positive (42.1%), when the cutoff for the thickness of the endometrium was 5 mm; however acuracy improved when the measure of 8 mm was used. The cutoff of 8 mm was determined through the ROC curve.
